Search Results for 'sof hcv'

sof hcv published presentations and documents on DocSlides.

SMV + DCV + SOF Open label

SMV + DCV + SOF Open label

by summer

≥ 18 years. Chronic HCV infection. Genotype 1 or...

Simplified HCV Therapy in 2018

Simplified HCV Therapy in 2018

by phoebe-click

This program is s. upported. by educational gran...

Treatment of Chronic HCV

Treatment of Chronic HCV

by lam

with Direct-Acting Antivirals (DAAs). www.hcvguide...

EASL 2019 HCV Conference Update

EASL 2019 HCV Conference Update

by sophia

April 10. –14. , 2019. Vienna, Austria. Disclaim...

by trish-goza

400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...

by lois-ondreau

400/100 mg . qd. N = 500. N = 100. W12. Placebo. ...

by conchita-marotz

Open-label. Chronic HCV infection. Genotype 1 . F...

SMV 150 mg QD SOF 400 mg QD

SMV 150 mg QD SOF 400 mg QD

by alida-meadow

Randomisation. 1 : 1. 18-70 years. HCV genotype 1...

Daclatasvir in Combination With Sofosbuvir

Daclatasvir in Combination With Sofosbuvir

by mitsue-stanley

With Or Without Ribavirin Is Safe and Efficacious...

FISSION Design Objective

FISSION Design Objective

by travis

Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...

Slides for today’s webinar are available on the CIHS website at:

Slides for today’s webinar are available on the CIHS website at:

by tatiana-dople

Slides for today’s webinar are available on the...

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

by kittie-lecroy

Interim Analysis of a French Multicenter Compassi...

ALLY-3 Design Objective SVR

ALLY-3 Design Objective SVR

by mitsue-stanley

12. (HCV RNA < 25 IU/ml), . with. 95% CI. DC...

by aaron

Design. Objective. SVR. 12. (HCV RNA < 25 IU/...

by tawny-fly

Design. Objective. SVR. 12. (HCV RNA < 25 IU/...

LDV/SOF 90/400 mg

LDV/SOF 90/400 mg

by aaron

qd. Non-randomised. Open-label. N =. 21. W12. SV...

Hepatitis C Drug Pipeline

Hepatitis C Drug Pipeline

by cheryl-pisano

HCV WORLD CAB .  FEBRUARY 2014. BANGKOK, THAI...

Daclatasvir in Combination With Sofosbuvir

Daclatasvir in Combination With Sofosbuvir

by mitsue-stanley

With Or Without Ribavirin Is Safe and Efficacious...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

by danika-pritchard

IAPAC African Regional Capacity-Building Hub. Bas...

Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis

Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis

by ahmir

ASTRAL-4. Source: Curry MP, et al. N Engl J Med. 2...

Use of HCV DAAs with HIV Regimens

Use of HCV DAAs with HIV Regimens

by robaut

Sam Lam, . PharmD. Annie Vong, . PharmD. 2/3/2017....

Prevention strategies for HIV/HCV co infection

Prevention strategies for HIV/HCV co infection

by giovanna-bartolotta

Isabelle Andrieux-Meyer, MD. Médecins Sans Front...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

by trish-goza

IAPAC African Regional Capacity-Building Hub. Bas...

by tawny-fly

Placebo. LDV/SOF + placebo. Randomisation*. 1 : 1...

by faustina-dinatale

qd. + SOF 400 mg . qd. N = 40. W12. 18-70 years....

by briana-ranney

Design. LDV/SOF. Open-label. ION-4 . Study. : LDV...

Ledipasvir-Sofosbuvir ( Harvoni

Ledipasvir-Sofosbuvir ( Harvoni

by sherrill-nordquist

). Slide deck prepared . by: . David H. Spach, MD...

Safety and Efficacy of Daclatasvir

Safety and Efficacy of Daclatasvir

by tabitha

. Plus . Sofosbuvir. With or Without Ribavirin . ...

by faustina-dinatale

Design. Open-label. CURRY . Study. : SOF + RBV fo...

Hepatitis C: A New Era In Treatment And Cure

Hepatitis C: A New Era In Treatment And Cure

by myesha-ticknor

Adam . Deising. , DO. LCDR MC USN. Director of . ...

Community Pharmacy Considerations for HIV

Community Pharmacy Considerations for HIV

by tawny-fly

& HCV . Therapy. Larry Pineda, . PharmD. , . ...

Use the Web Browser on Your Mobile Device to Participate in Polling*

Use the Web Browser on Your Mobile Device to Participate in Polling*

by phoebe-click

Go to: pollev.com/CCO2. or scan the QR code below...

Ledipasvir-Sofosbuvir (

Ledipasvir-Sofosbuvir (

by lindy-dunigan

Harvoni. ). Prepared by: . David H. Spach, MD and...

Are Pan-Genotypic Therapies Ready for Prime Time?

Are Pan-Genotypic Therapies Ready for Prime Time?

by lois-ondreau

3. Rd. International . HIV/Hepatitis . Coinfecti...

HIV and HCV Update for the Pharmacist – June 2014

HIV and HCV Update for the Pharmacist – June 2014

by marina-yarberry

John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. R...

Out With the Old and In With the New, Again?

Out With the Old and In With the New, Again?

by test

Out With the Old, In With the New. Current Standa...

by olivia-moreira

. + Sofosbuvir +/- Ribavirin in Genotype 1. COS...

NIAID ERADICATE

NIAID ERADICATE

by tatiana-dople

Open-label. W12. ≥ 18 years. Chronic HCV infect...

Updated Guidelines for Managing HIV/HCV Co-Infection

Updated Guidelines for Managing HIV/HCV Co-Infection

by karlyn-bohler

John J . Faragon. , . PharmD. , BCPS, AAHIV-P. Re...